Developer docs
API playgroundTry for free, no card

Search company profiles

agoko

Full company profile

uuid02m3dtc

Namestring
agoko
Legal namestring
Histidea NV
Websiteurl
histidea.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Histidea NV, operating under the brand agoko.be and headquartered in Sinaai, Belgium, provides a digital pathology platform (SlideSpace) alongside a broad portfolio of specialized pathology, histology, and cytology services. The company serves four primary customer segments — biopharma and pharmaceutical research, clinical laboratories, academic and institutional research organizations, and healthcare AI developers — through an enterprise-focused go-to-market with direct sales engagement and contact-based pricing. Service offerings span preclinical tissue processing and toxicology assessment, clinical trial support including central pathology review and biomarker testing, specialized analytics such as immunohistochemistry, in situ hybridization, and multiplex immunofluorescence, and a dedicated AI Development Services line covering dataset creation, expert annotation, algorithm validation, and workflow implementation.

The core technology is SlideSpace, a cloud-based digital pathology platform that enables secure slide sharing, real-time annotation and commenting, case management, and integration with laboratory information systems and AI modules. SlideSpace is delivered with end-to-end encryption, GDPR-compliant data handling, and device-agnostic access, allowing the company to position itself as a globally accessible collaboration layer. Underpinning the platform is a contracted network of over 60 board-certified pathologists with subspecialty coverage across dermatopathology, GI, gynecologic, hematopathology, neuropathology, oncologic, pulmonary, urologic pathology, cytopathology, and molecular pathology — the operating asset that converts the platform into service delivery.

Revenue is generated primarily through professional services engagements (preclinical research, clinical trial pathology support, specialized analytics, consulting, AI dataset creation, annotation, validation, and implementation support), with SlideSpace positioned as a subscription or engagement-tied platform. The company maintains named enterprise relationships with MSD, EORTC, ContextVision, Spatial Transcriptomics, TILS, BQA, the University of Antwerp, and Bonadea. Histidea is privately held with no disclosed funding rounds, parent company, or institutional investors in the available data, and reports 1–10 internal employees coordinating the broader pathologist network.

Short descriptiontext

Histidea (operating as agoko.be) provides the SlideSpace digital pathology platform and specialized pathology, histology, and AI development services to biopharma, clinical laboratories, research organizations, and healthcare AI developers, leveraging a network of 60+ board-certified pathologists.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSinaai, Belgium
HQ citystring
Sinaai
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital pathology services, histopathology analysis, clinical trial pathology, AI annotation services, whole slide imaging
Industry6 codes
PRIMARYHLAGAEAC
Anatomic Pathology & Histopathology (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAAALAI
Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
NAICS code3 codes
  • Medical and Diagnostic Laboratories62151
  • Medical Laboratories621511
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Digital Pathology Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model9 records
1Preclinical Pathology Services
TypeProfessional Services
Description

Tissue processing and analysis, toxicology assessment, efficacy evaluation, and animal model expertise for pharmaceutical research.

histidea.com
2Clinical Trial Support Services
TypeProfessional Services
Description

Central pathology review, biomarker testing, and pathological response assessment for pharmaceutical research clinical trials.

histidea.com
3Specialized Analytics
TypeProfessional Services
Description

Advanced histopathology analysis including immunohistochemistry (IHC), histochemical stains, in situ hybridization, multiplex immunofluorescence, and quantitative image analysis.

histidea.com
4Consulting Services
TypeProfessional Services
Description

Expert pathology consulting including study design consultation, pathology working groups, data interpretation, and laboratory optimization.

histidea.com
5AI Development Services
TypeProfessional Services
Description

Custom dataset creation for AI training including annotated whole slide image libraries, disease-specific datasets, and multi-modal datasets with diverse patient representation and metadata.

histidea.com
6Annotation Services
TypeProfessional Services
Description

Expert pathologist annotations, consensus review, semantic segmentation, and object detection for medical AI development.

histidea.com
7Validation Services
TypeProfessional Services
Description

Algorithm testing, comparative analysis, and edge case identification for pathology AI algorithms by expert pathologists.

histidea.com
8Implementation Support
TypeProfessional Services
Description

Professional support for implementing AI solutions in pathology workflows including integration consulting, performance monitoring, feedback loops, and educational programs.

histidea.com
9SlideSpace Platform
TypeSubscription Recurring
Description

Digital pathology platform subscription for collaborative workflows, potentially as part of service engagement.

histidea.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1SlideSpace
Description

Histidea's all-inclusive platform for collaborative digital pathology workflows, enabling cloud-based slide access, secure sharing, real-time collaboration, case management, and integration with laboratory information systems and AI modules.

histidea.com
Core offering1 text field

Agoko (operating as Histidea NV) provides specialized pathology and histology services to biopharma, clinical laboratories, research organizations, and healthcare AI developers. Its core offering combines a network of 60+ board-certified pathologists across all subspecialties with the SlideSpace cloud-based digital pathology platform for collaborative slide review, annotation, and case management. Services span preclinical tissue evaluation, clinical trial central pathology review, biomarker testing, immunohistochemistry and multiplex immunofluorescence analytics, expert consulting, AI training dataset creation, expert annotation, algorithm validation, and implementation support.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Histidea offers a platform-plus-services architecture combining SlideSpace (a cloud-based digital pathology platform) with specialized pathology and histology services. The SlideSpace platform enables collaborative digital pathology workflows including cloud slide access, annotation, case management, and integration with AI modules. Supporting services include preclinical pathology, clinical trial support, specialized analytics (IHC, multiplex immunofluorescence), consulting, AI dataset creation, annotation, validation, and implementation support. A network of over 60 board-certified pathologists provides expert coverage across all histopathology subspecialties.

Product and service9 records
1SlideSpace Digital Pathology Platform
CategoryDigital Pathology Software Platform
Description

Cloud-based platform that enables pathologists and researchers to view, share, annotate, and manage whole slide images and cases from any device, with secure cloud storage, real-time collaboration, and integration with laboratory information systems and AI modules. Targeted at biopharma, clinical laboratories, research organizations, and AI developers needing collaborative pathology workflows.

2Preclinical Pathology Services
CategoryPreclinical Research Services
Description

Tissue processing and analysis, toxicology assessment, efficacy evaluation, and animal model pathology expertise for pharmaceutical and biotech preclinical drug development programs. Delivered by Histidea's subspecialty pathologist network.

3Clinical Trial Support Services
CategoryClinical Trial Services
Description

Central pathology review, biomarker testing, and pathological response assessment services for pharmaceutical clinical trials, including digital pathology solutions for multi-site studies. Targeted at clinical trial sponsors and research organizations.

4Specialized Histopathology Analytics
CategorySpecialty Laboratory Analytics
Description

Advanced histopathology analysis techniques including immunohistochemistry (IHC), histochemical stains, in situ hybridization, multiplex immunofluorescence, and quantitative image analysis for research and clinical customers needing specialized staining and imaging analytics.

5Pathology Consulting Services
CategoryConsulting Services
Description

Expert pathology consulting including study design consultation, pathology working groups, data interpretation, and laboratory organization and optimization for biopharma, research, and clinical lab clients.

6AI Dataset Creation Services
CategoryAI Training Data Services
Description

Custom creation of annotated whole slide image (WSI) libraries, disease-specific datasets, and multi-modal datasets with diverse patient representation and metadata, designed to train pathology and medical imaging AI models. Targeted at healthcare AI developers.

7Pathology Annotation Services
CategoryAI Annotation Services
Description

Professional annotation services by board-certified pathologists, including expert annotations, consensus review, semantic segmentation, and object detection on whole slide images for medical AI development.

8AI Validation Services
CategoryAI Validation Services
Description

Algorithm testing, comparative analysis, and edge case identification performed by expert pathologists to validate pathology AI algorithms prior to deployment. Targeted at healthcare AI developers.

9AI Implementation Support Services
CategoryAI Implementation Services
Description

Professional support for implementing AI solutions in pathology workflows, including integration consulting, performance monitoring, feedback loops, and educational programs for healthcare AI customers rolling out models into clinical practice.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major oncology research organization partnership for clinical pathology support and histopathology services in cancer research trials.

2MSD
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical research partnership providing pathology and histology services for clinical trial support and drug development.

histidea.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic research collaboration with university research institution for pathology expertise and research projects.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Proscia offers a cloud-based digital pathology platform with AI integrations for life sciences and clinical use — directly competing with SlideSpace on the platform layer.

TypeEmerging player
Description

PathAI develops AI-powered pathology algorithms and operates a diagnostic and biopharma services business that consumes large annotated pathology datasets — comparable to Histidea on the AI services and dataset creation side.

TypeBroad incumbent
Description

Labcorp's drug development arm operates one of the largest global central labs with anatomic pathology services for clinical trials — a broad incumbent competing for the same pharma trial support work as Histidea.

TypeBroad incumbent
Description

Q² Solutions is a joint venture central lab offering clinical trial laboratory services including anatomic pathology and biomarker testing — a large incumbent competing in the same trial-support pathology space as Histidea.

TypeDirect peer
Description

NeoGenomics provides oncology-focused pathology and biomarker services to pharma clinical trials and is a direct competitor in central pathology review and clinical trial histology support.

TypeEmerging player
Description

Indica Labs provides digital pathology image analysis software (HALO) widely used in pharma research and AI workflows — competing with SlideSpace for AI-enablement and quantitative image analysis work.

TypeDirect peer
Description

Pharmatest Services is a preclinical CRO offering in vivo efficacy, toxicology, and histopathology services — directly comparable to Histidea's preclinical pathology, toxicology assessment, and animal model expertise offerings.

TypeDirect peer
Description

Cerba Research is a central lab and specialty biomarker services provider for clinical trials, including anatomic pathology and IHC — competing with Histidea for the same biopharma central pathology and biomarker testing engagements.

TypeDirect peer
Description

CellCarta (formed from the merger of HistoGeneX and Caprion) is a histopathology and biomarker services provider serving pharma clinical trials and AI developers — directly comparable to Histidea's central pathology review, IHC, multiplex immunofluorescence, and AI dataset services.

10Aignostics
TypeEmerging player
Description

Aignostics is a Berlin-based AI digital pathology company combining computational pathology with pathologist expertise — overlapping with Histidea's AI development services and SlideSpace platform offering for AI developers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

agoko

Digital Pathology Serviceshistidea.com

Histidea (operating as agoko.be) provides the SlideSpace digital pathology platform and specialized pathology, histology, and AI development services to biopharma, clinical laboratories, research organizations, and healthcare AI developers, leveraging a network of 60+ board-certified pathologists.

What agoko does

Histidea NV, operating under the brand agoko.be and headquartered in Sinaai, Belgium, provides a digital pathology platform (SlideSpace) alongside a broad portfolio of specialized pathology, histology, and cytology services. The company serves four primary customer segments — biopharma and pharmaceutical research, clinical laboratories, academic and institutional research organizations, and healthcare AI developers — through an enterprise-focused go-to-market with direct sales engagement and contact-based pricing. Service offerings span preclinical tissue processing and toxicology assessment, clinical trial support including central pathology review and biomarker testing, specialized analytics such as immunohistochemistry, in situ hybridization, and multiplex immunofluorescence, and a dedicated AI Development Services line covering dataset creation, expert annotation, algorithm validation, and workflow implementation.

The core technology is SlideSpace, a cloud-based digital pathology platform that enables secure slide sharing, real-time annotation and commenting, case management, and integration with laboratory information systems and AI modules. SlideSpace is delivered with end-to-end encryption, GDPR-compliant data handling, and device-agnostic access, allowing the company to position itself as a globally accessible collaboration layer. Underpinning the platform is a contracted network of over 60 board-certified pathologists with subspecialty coverage across dermatopathology, GI, gynecologic, hematopathology, neuropathology, oncologic, pulmonary, urologic pathology, cytopathology, and molecular pathology — the operating asset that converts the platform into service delivery.

Revenue is generated primarily through professional services engagements (preclinical research, clinical trial pathology support, specialized analytics, consulting, AI dataset creation, annotation, validation, and implementation support), with SlideSpace positioned as a subscription or engagement-tied platform. The company maintains named enterprise relationships with MSD, EORTC, ContextVision, Spatial Transcriptomics, TILS, BQA, the University of Antwerp, and Bonadea. Histidea is privately held with no disclosed funding rounds, parent company, or institutional investors in the available data, and reports 1–10 internal employees coordinating the broader pathologist network.

agoko firmographics

Firmographics
Name
agoko
Legal name
Histidea NV
Website
https://histidea.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Histidea (operating as agoko.be) provides the SlideSpace digital pathology platform and specialized pathology, histology, and AI development services to biopharma, clinical laboratories, research organizations, and healthcare AI developers, leveraging a network of 60+ board-certified pathologists.
Ownership category
akta.pro rank

agoko industry classification

Industry
Product category
Digital Pathology Services
NAICS
Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Scientific Research and Development Services (5417)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAEAC
Anatomic Pathology & Histopathology (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAAALAI
Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)

Keywords

  • Digital pathology services
  • Histopathology analysis
  • Clinical trial pathology
  • AI annotation services
  • Whole slide imaging

Where agoko is headquartered

Location

Headquarters

HQ city
Sinaai
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

agoko business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Preclinical Pathology Services: Tissue processing and analysis, toxicology assessment, efficacy evaluation, and animal model expertise for pharmaceutical research.
  2. Clinical Trial Support Services: Central pathology review, biomarker testing, and pathological response assessment for pharmaceutical research clinical trials.
  3. Specialized Analytics: Advanced histopathology analysis including immunohistochemistry (IHC), histochemical stains, in situ hybridization, multiplex immunofluorescence, and quantitative image analysis.
  4. Consulting Services: Expert pathology consulting including study design consultation, pathology working groups, data interpretation, and laboratory optimization.
  5. AI Development Services: Custom dataset creation for AI training including annotated whole slide image libraries, disease-specific datasets, and multi-modal datasets with diverse patient representation and metadata.
  6. Annotation Services: Expert pathologist annotations, consensus review, semantic segmentation, and object detection for medical AI development.
  7. Validation Services: Algorithm testing, comparative analysis, and edge case identification for pathology AI algorithms by expert pathologists.
  8. Implementation Support: Professional support for implementing AI solutions in pathology workflows including integration consulting, performance monitoring, feedback loops, and educational programs.
  9. SlideSpace Platform: Digital pathology platform subscription for collaborative workflows, potentially as part of service engagement.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

agoko product offering

Product offering

Core offering

Agoko (operating as Histidea NV) provides specialized pathology and histology services to biopharma, clinical laboratories, research organizations, and healthcare AI developers. Its core offering combines a network of 60+ board-certified pathologists across all subspecialties with the SlideSpace cloud-based digital pathology platform for collaborative slide review, annotation, and case management. Services span preclinical tissue evaluation, clinical trial central pathology review, biomarker testing, immunohistochemistry and multiplex immunofluorescence analytics, expert consulting, AI training dataset creation, expert annotation, algorithm validation, and implementation support.

Product overview

Histidea offers a platform-plus-services architecture combining SlideSpace (a cloud-based digital pathology platform) with specialized pathology and histology services. The SlideSpace platform enables collaborative digital pathology workflows including cloud slide access, annotation, case management, and integration with AI modules. Supporting services include preclinical pathology, clinical trial support, specialized analytics (IHC, multiplex immunofluorescence), consulting, AI dataset creation, annotation, validation, and implementation support. A network of over 60 board-certified pathologists provides expert coverage across all histopathology subspecialties.

Differentiator

Problem solved

Functional benefit

Brands

  • SlideSpace: Histidea's all-inclusive platform for collaborative digital pathology workflows, enabling cloud-based slide access, secure sharing, real-time collaboration, case management, and integration with laboratory information systems and AI modules.

Products and services

  • SlideSpace Digital Pathology Platform Cloud-based platform that enables pathologists and researchers to view, share, annotate, and manage whole slide images and cases from any device, with secure cloud storage, real-time collaboration, and integration with laboratory information systems and AI modules. Targeted at biopharma, clinical laboratories, research organizations, and AI developers needing collaborative pathology workflows.
  • Preclinical Pathology Services Tissue processing and analysis, toxicology assessment, efficacy evaluation, and animal model pathology expertise for pharmaceutical and biotech preclinical drug development programs. Delivered by Histidea's subspecialty pathologist network.
  • Clinical Trial Support Services Central pathology review, biomarker testing, and pathological response assessment services for pharmaceutical clinical trials, including digital pathology solutions for multi-site studies. Targeted at clinical trial sponsors and research organizations.
  • Specialized Histopathology Analytics Advanced histopathology analysis techniques including immunohistochemistry (IHC), histochemical stains, in situ hybridization, multiplex immunofluorescence, and quantitative image analysis for research and clinical customers needing specialized staining and imaging analytics.
  • Pathology Consulting Services Expert pathology consulting including study design consultation, pathology working groups, data interpretation, and laboratory organization and optimization for biopharma, research, and clinical lab clients.
  • AI Dataset Creation Services Custom creation of annotated whole slide image (WSI) libraries, disease-specific datasets, and multi-modal datasets with diverse patient representation and metadata, designed to train pathology and medical imaging AI models. Targeted at healthcare AI developers.
  • Pathology Annotation Services Professional annotation services by board-certified pathologists, including expert annotations, consensus review, semantic segmentation, and object detection on whole slide images for medical AI development.
  • AI Validation Services Algorithm testing, comparative analysis, and edge case identification performed by expert pathologists to validate pathology AI algorithms prior to deployment. Targeted at healthcare AI developers.
  • AI Implementation Support Services Professional support for implementing AI solutions in pathology workflows, including integration consulting, performance monitoring, feedback loops, and educational programs for healthcare AI customers rolling out models into clinical practice.

Companies that use agoko

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

agoko technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

agoko partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • EORTC (European Organisation for Research and Treatment of Cancer)coreStrategic or Co-development PartnerMajor oncology research organization partnership for clinical pathology support and histopathology services in cancer research trials.
  • MSDcoreStrategic or Co-development PartnerPharmaceutical research partnership providing pathology and histology services for clinical trial support and drug development.
  • University of AntwerpminorStrategic or Co-development PartnerAcademic research collaboration with university research institution for pathology expertise and research projects.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

agoko competitors and assessment

Company assessment

Emerging players

  • Proscia: Proscia offers a cloud-based digital pathology platform with AI integrations for life sciences and clinical use — directly competing with SlideSpace on the platform layer.
  • PathAI: PathAI develops AI-powered pathology algorithms and operates a diagnostic and biopharma services business that consumes large annotated pathology datasets — comparable to Histidea on the AI services and dataset creation side.
  • Indica Labs: Indica Labs provides digital pathology image analysis software (HALO) widely used in pharma research and AI workflows — competing with SlideSpace for AI-enablement and quantitative image analysis work.
  • Aignostics: Aignostics is a Berlin-based AI digital pathology company combining computational pathology with pathologist expertise — overlapping with Histidea's AI development services and SlideSpace platform offering for AI developers.

Broad incumbents

  • Labcorp Drug Development (formerly Covance): Labcorp's drug development arm operates one of the largest global central labs with anatomic pathology services for clinical trials — a broad incumbent competing for the same pharma trial support work as Histidea.
  • Q² Solutions: Q² Solutions is a joint venture central lab offering clinical trial laboratory services including anatomic pathology and biomarker testing — a large incumbent competing in the same trial-support pathology space as Histidea.

Direct peers

  • NeoGenomics: NeoGenomics provides oncology-focused pathology and biomarker services to pharma clinical trials and is a direct competitor in central pathology review and clinical trial histology support.
  • Pharmatest Services: Pharmatest Services is a preclinical CRO offering in vivo efficacy, toxicology, and histopathology services — directly comparable to Histidea's preclinical pathology, toxicology assessment, and animal model expertise offerings.
  • Cerba Research: Cerba Research is a central lab and specialty biomarker services provider for clinical trials, including anatomic pathology and IHC — competing with Histidea for the same biopharma central pathology and biomarker testing engagements.
  • CellCarta: CellCarta (formed from the merger of HistoGeneX and Caprion) is a histopathology and biomarker services provider serving pharma clinical trials and AI developers — directly comparable to Histidea's central pathology review, IHC, multiplex immunofluorescence, and AI dataset services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

agoko social profiles

Digital presence

agoko compliance and trust

Trust signal

Compliance1 record

agoko financial estimates

Financial estimate

Revenue estimate

Valuation estimate

agoko leadership team

Management profile

Number of profiles

agoko funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

agoko M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about agoko

What does agoko do?

Agoko (operating as Histidea NV) provides specialized pathology and histology services to biopharma, clinical laboratories, research organizations, and healthcare AI developers. Its core offering combines a network of 60+ board-certified pathologists across all subspecialties with the SlideSpace cloud-based digital pathology platform for collaborative slide review, annotation, and case management. Services span preclinical tissue evaluation, clinical trial central pathology review, biomarker testing, immunohistochemistry and multiplex immunofluorescence analytics, expert consulting, AI training dataset creation, expert annotation, algorithm validation, and implementation support.

Is agoko a public or private company?

agoko is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was agoko founded?

agoko was founded in 2015. It employs 1 to 10 people.

Where is agoko based?

agoko is headquartered in Sinaai, Belgium, in the Europe region.

How does agoko make money?

Nine revenue lines are on record. Preclinical Pathology Services are the primary driver. The others are clinical Trial Support Services, specialized Analytics, consulting Services, AI Development Services, annotation Services, validation Services, implementation Support and slideSpace Platform.

Who are agoko's main competitors?

Emerging players on record are Proscia, PathAI, Indica Labs and Aignostics. Broad incumbents are Labcorp Drug Development (formerly Covance) and Q² Solutions. Direct peers are NeoGenomics, Pharmatest Services, Cerba Research and CellCarta.

Does agoko have an API?

No public API is recorded for agoko.

What industry is agoko in?

agoko's product category is Digital Pathology Services. Its primary akta.pro industry code is HLAGAEAC, Anatomic Pathology & Histopathology (Trial Support), with a secondary code of HLAGAFAI, Pathology & Histopathology Services. Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales